BMC Infectious Diseases

official impact factor 2.83

Open Access Research article

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

Jaromir Mikl*, Mark S Sulkowski, Yves Benhamou, Douglas Dieterich, Stanislas Pol, Jürgen Rockstroh, Patrick A Robinson, Mithun Ranga and Jerry O Stern

BMC Infectious Diseases 2009, 9:203 doi:10.1186/1471-2334-9-203

No comments have yet been made on this article.

Post a comment